Hepion Pharmaceuticals, Inc. (ticker: HEPA) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of HEPA's SEC filings surfaces 9 active risk signals, including 7 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. HEPA reported $0 in revenue and -$811K for the period ending 2024-03-31, with operating cash flow of $579K. Cash and equivalents stood at $2.60M (down 43.3% year-over-year). Total assets of $2.71M exceed total liabilities of $849K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
HEPA SEC Filings
Full cached SEC EDGAR filing history for HEPA, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.